Get the Stockscreener App
0.9446
7.46%
0.0656
Allarity Therapeutics Inc stock is traded at $0.9446, with a volume of 317.51K.
It is up +7.46% in the last 24 hours and down -5.04% over the past month.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
See More
Previous Close:
$0.879
Open:
$0.8717
24h Volume:
317.51K
Relative Volume:
0.72
Market Cap:
$14.24M
Revenue:
-
Net Income/Loss:
$-11.90M
P/E Ratio:
-0.00459
EPS:
-206.0125
Net Cash Flow:
$-12.75M
1W Performance:
-1.40%
1M Performance:
-5.04%
6M Performance:
-0.93%
1Y Performance:
+434.58%
1-Day Range:
$0.8717
$0.9623
1-Week Range:
$0.84
$0.9623
52-Week Range:
$0.1131
$3.95
Allarity Therapeutics Inc Stock (ALLR) Company Profile
Name
Allarity Therapeutics Inc
Sector
Industry
Phone
401-426-4664
Address
24 SCHOOL ST., 2ND FLOOR, BOSTON
Compare ALLR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALLR
Allarity Therapeutics Inc
|
0.9446 | 13.72M | 0 | -11.90M | -12.75M | -206.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Initiated | Ascendiant Capital Markets | Buy |
Allarity Therapeutics Inc Stock (ALLR) Latest News
How to forecast Allarity Therapeutics Inc. trends using time seriesTrade Volume Report & Weekly Return Optimization Alerts - Newser
Allarity Therapeutics Delays 10-Q Filing - MSN
Stock Market Today: Nasdaq 100 Futures Slip— Palo Alto, XP, Allarity Earnings In Focus (UPDATED) - Benzinga
What machine learning models say about Allarity Therapeutics Inc.Earnings Risk Report & Verified Swing Trading Watchlists - Newser
Palo Alto Networks, Fabrinet And 3 Stocks To Watch Heading Into Monday - Benzinga
Published on: 2025-08-18 10:13:44 - beatles.ru
Volatility clustering patterns for Allarity Therapeutics Inc.July 2025 Update & Safe Capital Allocation Plans - Newser
Why Allarity Therapeutics Inc. stock attracts strong analyst attentionPortfolio Risk Summary & Reliable Price Action Trade Plans - Newser
How to use Fibonacci retracement on Allarity Therapeutics Inc.July 2025 PostEarnings & Free Real-Time Volume Trigger Notifications - Newser
Is Allarity Therapeutics Inc. forming a reversal patternWeekly Loss Report & Fast Exit and Entry Trade Guides - Newser
Momentum divergence signals in Allarity Therapeutics Inc. chart2025 Support & Resistance & Fast Gaining Stock Reports - Newser
Allarity Therapeutics Inc. stock volume spike explainedEarnings Growth Report & Free Community Consensus Stock Picks - Newser
Top chart patterns to watch in Allarity Therapeutics Inc.Weekly Trade Review & Capital Efficient Trading Techniques - Newser
Statistical indicators supporting Allarity Therapeutics Inc.’s strengthJuly 2025 Market Mood & Fast Exit and Entry Strategy Plans - Newser
Advanced analytics toolkit walkthrough for Allarity Therapeutics Inc.Quarterly Market Summary & Reliable Breakout Forecasts - Newser
Will Allarity Therapeutics Inc. stock benefit from interest rate changesCPI Data & Stock Portfolio Risk Management - Newser
What makes Allarity Therapeutics Inc. stock price move sharplyInflation Watch & Accurate Entry and Exit Point Alerts - kangso.co.kr
Chart based analysis of Allarity Therapeutics Inc. trends2025 Bull vs Bear & Daily Growth Stock Investment Tips - Newser
Allarity Therapeutics Provides Second Quarter 2025 Update, - GlobeNewswire
Order flow analysis tools used on Allarity Therapeutics Inc.2025 Trading Recap & Technical Entry and Exit Alerts - Newser
Allarity Therapeutics Delays Q2 Earnings Report Due to Audit Review - AInvest
How Allarity Therapeutics Inc. stock performs during market volatilityEarnings Growth Report & Precise Swing Trade Entry Alerts - Newser
Short interest data insights for Allarity Therapeutics Inc.Quarterly Profit Review & Low Risk High Win Rate Stock Picks - Newser
Momentum Indicator Shows Bearish Divergence in Allarity Therapeutics Inc.Bear Alert & Stepwise Trade Signal Implementation - beatles.ru
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP - Bluefield Daily Telegraph
Allarity Therapeutics, Inc. SEC 10-Q Report - TradingView
First Patients Dosed: Allarity's Dual-Action Cancer Drug Stenoparib Enters Critical Phase 2 Trial - Stock Titan
Price action breakdown for Allarity Therapeutics Inc.Weekly Trend Recap & Low Risk Profit Maximizing Plans - Newser
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships - Business Upturn
Will Allarity Therapeutics Inc. bounce back from current support2025 Historical Comparison & Entry Point Strategy Guides - Newser
Chart overlay techniques for tracking Allarity Therapeutics Inc.New Guidance & Safe Entry Momentum Tips - Newser
Identifying reversal signals in Allarity Therapeutics Inc.Market Risk Analysis & Weekly High Potential Alerts - Newser
Allarity Therapeutics Inc. Included in Top Momentum ScanWeekly Trading Summary & Reliable Price Breakout Signals - newsyoung.net
Earnings visualization tools for Allarity Therapeutics Inc.Weekly Trade Analysis & Consistent Income Trade Ideas - Newser
Is Allarity Therapeutics Inc. the Top Chart Pick This WeekJuly 2025 Chart Watch & Target Return Focused Stock Picks - newsyoung.net
Analyzing Allarity Therapeutics Inc. with multi timeframe chartsPortfolio Profit Report & Stock Market Timing Techniques - Newser
Identifying reversal signals in Allarity Therapeutics Inc. [July 2025 Intraday Action]AI Powered Market Entry Ideas - Newser
What MACD signals say about Allarity Therapeutics Inc.Free Early Entry Picks Before News Breakout - Newser
Strategies to average down on Allarity Therapeutics Inc.Weekly Chart Watchlist with Trade Guidance - Newser
Allarity Therapeutics Inc Stock (ALLR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):